Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer
Peripheral blood lymphocyte count is a simple and effective biomarker that can be used to identify patients with liver cancer who will benefit more from TKI+PD-1 combination therapy.
Authors
- Qiankun Xie (ORCID: https://orcid.org/0000-0002-2635-7193)
- Qian Zhao (ORCID: https://orcid.org/0000-0002-9305-3667)
- Huilan Fu
- Yuqin Zhang (ORCID: https://orcid.org/0000-0002-4872-0889)
- Lei Wang (ORCID: https://orcid.org/0000-0001-7449-2763)
Institutions
- Nanfang Hospital (CN)
- Guangzhou Development Zone Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3389/fimmu.2024.1467429
- Citations
- 1
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.24
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Southern Medical University
- Nanfang Hospital